Renovaro Biosciences
RENB
#8801
Rank
โ‚น8.21 B
Marketcap
โ‚น50.81
Share price
-4.43%
Change (1 day)
-80.49%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -โ‚น160.30

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -โ‚น170.50. In 2022 the company made an earnings per share (EPS) of -โ‚น173.88 a decrease over its 2021 EPS that were of -โ‚น66.68.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น160.30-7.81%
2022-โ‚น173.88160.76%
2021-โ‚น66.68243.48%
2020-โ‚น19.4143.75%
2019-โ‚น13.51-74.87%
2018-โ‚น53.74339.47%
2017-โ‚น12.23-48.26%
2016-โ‚น23.63-22.22%
2015-โ‚น30.397.39%
2014-โ‚น28.304351.27%
2013-โ‚น0.6416.6%
2012-โ‚น0.55